Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Annual account missing NBB
Fiscal year 2023 was expected before 30 January 2024 and has not been filed.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2022
DR. SPENDLOVE from Maaseik, company number BE0865898214, closed financial year 2022 with a result of € 14,902 after tax. For that financial year DR. SPENDLOVE recorded a gross margin of € 48,052 and equity of € 24,406. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 14, 2023.
€ 24,406
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 14,902
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2022. Retained profit grew to € 4,406.
People and assets in 2022
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 759
Book value of vehicles, furniture and equipment.
Debts at end 2022
€ 268,111
€ 19,387 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 980
Supplier invoices still open on the last day of the fiscal year.
€ 2,564
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to DR. SPENDLOVE?
What happened at DR. SPENDLOVE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2022: profit of € 14,902. filed late Source: NBB ↗
- New establishment in Maaseik. KBO
- Start of the company according to the CBE. KBO
- Danny Spendlove became a director. NBB
In short
Paid € 2,564 in corporate taxes since 2022.
A new publication or filing at DR. SPENDLOVE? We notify you, reason included.
Follow DR. SPENDLOVEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind DR. SPENDLOVE is Danny Spendlove.
Directors
According to the 2022 annual accounts
Danny Spendlove
Administrator-manager
since 2004
Establishments
Establishment units
Physical locations of this company
Tismansweg 28
3680 Maaseik
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0865.898.214
- VAT number
- BE 0865.898.214
- Registered office
- Tismansweg 28, 3680 Maaseik
- Names & denominations
- DR. SPENDLOVE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 June 2004
- Peppol
- Not registered